These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28011211)

  • 1. 2-Guanidino-quinazolines as a novel class of translation inhibitors.
    Komarova Andreyanova ES; Osterman IA; Pletnev PI; Ivanenkov YA; Majouga AG; Bogdanov AA; Sergiev PV
    Biochimie; 2017 Feb; 133():45-55. PubMed ID: 28011211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted Furanocoumarins as Novel Class of Antibacterial Translation Inhibitors.
    Ivanenkov YA; Yamidanov RS; Osterman IA; Sergiev PV; Ayginin AA; Aladinskiy VA; Aladinskaya AV; Terentiev VA; Veselov MS; Skvortsov DA; Komarova KS; Chemeris AV; Zainullina LF; Maximova MA; Zileeva ZR; Vakhitova YV; Baymiev AK; Baymiev AK; Sofronova AA; Machulkin AE; Petrov RA; Bezrukov DS; Puchinina MM; Lukianov DA; Dontsova OA
    Comb Chem High Throughput Screen; 2019; 22(6):400-410. PubMed ID: 31573876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents.
    Kung PP; Casper MD; Cook KL; Wilson-Lingardo L; Risen LM; Vickers TA; Ranken R; Blyn LB; Wyatt JR; Cook PD; Ecker DJ
    J Med Chem; 1999 Nov; 42(22):4705-13. PubMed ID: 10579832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the 6'-hydroxy group and its configuration for apramycin activity.
    Mandhapati AR; Shcherbakov D; Duscha S; Vasella A; Böttger EC; Crich D
    ChemMedChem; 2014 Sep; 9(9):2074-83. PubMed ID: 25045149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.
    Zhou Y; Gregor VE; Sun Z; Ayida BK; Winters GC; Murphy D; Simonsen KB; Vourloumis D; Fish S; Froelich JM; Wall D; Hermann T
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4942-9. PubMed ID: 16304156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antibacterial class: a series of tetracyclic derivatives.
    Hinman MM; Rosenberg TA; Balli D; Black-Schaefer C; Chovan LE; Kalvin D; Merta PJ; Nilius AM; Pratt SD; Soni NB; Wagenaar FL; Weitzberg M; Wagner R; Beutel BA
    J Med Chem; 2006 Aug; 49(16):4842-56. PubMed ID: 16884296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen.
    Novac O; Guenier AS; Pelletier J
    Nucleic Acids Res; 2004; 32(3):902-15. PubMed ID: 14769948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antimicrobial evaluation, and docking studies of novel 4-substituted quinazoline derivatives as DNA-gyrase inhibitors.
    Boyapati S; Kulandaivelu U; Sangu S; Vanga MR
    Arch Pharm (Weinheim); 2010 Oct; 343(10):570-6. PubMed ID: 20941729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.
    Doig P; Boriack-Sjodin PA; Dumas J; Hu J; Itoh K; Johnson K; Kazmirski S; Kinoshita T; Kuroda S; Sato TO; Sugimoto K; Tohyama K; Aoi H; Wakamatsu K; Wang H
    Bioorg Med Chem; 2014 Nov; 22(21):6256-69. PubMed ID: 25262942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving on nature: antibiotics that target the ribosome.
    Sutcliffe JA
    Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of novel antibacterial quinazolines.
    Bedi PM; Kumar V; Mahajan MP
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biochemical and biophysical tools for triage of high-throughput screening hits - A case study with Escherichia coli phosphopantetheine adenylyltransferase.
    Miller JR; Thanabal V; Melnick MM; Lall M; Donovan C; Sarver RW; Lee DY; Ohren J; Emerson D
    Chem Biol Drug Des; 2010 May; 75(5):444-54. PubMed ID: 20486930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Crystal Structure, and Agricultural Antimicrobial Evaluation of Novel Quinazoline Thioether Derivatives Incorporating the 1,2,4-Triazolo[4,3-
    Fan Z; Shi J; Luo N; Ding M; Bao X
    J Agric Food Chem; 2019 Oct; 67(42):11598-11606. PubMed ID: 31560195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
    Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and initial development of a novel class of antibacterials: inhibitors of Staphylococcus aureus transcription/translation.
    Larsen SD; Hester MR; Craig Ruble J; Kamilar GM; Romero DL; Wakefield B; Melchior EP; Sweeney MT; Marotti KR
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6173-7. PubMed ID: 17027262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
    Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
    Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants.
    Clark RF; Wang S; Ma Z; Weitzberg M; Motter C; Tufano M; Wagner R; Gu YG; Dandliker PJ; Lerner CG; Chovan LE; Cai Y; Black-Schaefer CL; Lynch L; Kalvin D; Nilius AM; Pratt SD; Soni N; Zhang T; Zhang X; Beutel BA
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3299-302. PubMed ID: 15149694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors.
    Lim CJ; Oh KS; Ha JD; Lee JH; Seo HW; Chae CH; Kim DG; Lee MJ; Lee BH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4080-3. PubMed ID: 25124116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.